secwatch / observer
8-K filed May 3, 2023, 7:59 PM ET ticker FUNI CIK 0001502966
M&A confidence high sentiment neutral materiality 0.70

Digipath agrees to sell cannabis testing lab assets for $2.3M; director resigns

Hypha Labs, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Bruce Raben

director
FUNI · Hypha Labs, Inc.
Effective
2023-05-02
Filed
May 3, 2023, 7:59 PM ET
On May 2, 2023, Bruce Raben submitted a letter to the Company resigning from his position as a director of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Bruce Raben resigned as director at Hypha Labs, Inc..

Action
resigned
Role
director
Exact text from the filing
On May 2, 2023, Bruce Raben submitted a letter to the Company resigning from his position as a director of the Company.
View on SEC.gov
Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.98

Hypha Labs, Inc. entered into Asset Purchase Agreement with DPL NV, LLC valued at cash purchase price of $2,300,000 (effective 2022-04-20).

Action
entry
Agreement
asset purchase
Counterparty
DPL NV, LLC
Value
cash purchase price of $2,300,000
Effective
2022-04-20
Exact text from the filing
On April 20, 2022, Digipath, Inc. (“the “Company”), and Digipath Labs, Inc. (“Digipath Labs”), a wholly-owned subsidiary of the Company, entered into an Asset Purchase Agreement (the “Purchase Agreement”) with DPL NV, LLC (“Buyer”), pursuant to which Digipath Labs has agreed to sell substantially all of its assets to Buyer for a cash purchase price of $2,300,000
View on SEC.gov

155 material agreements filed in the last 30 days. Browse all material agreements →

Hypha Labs, Inc. filing history →

Source: SEC EDGAR
accession 0001493152-23-015225
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.